Different embryo-fetal toxicity effects for three VLA-4 antagonists

被引:12
作者
Crofts, F
Pino, M
DeLise, B
Guittin, P
Barbellion, S
Brunel, P
Potdevin, S
Bergmann, B
Hofmann, T
Lerman, S
Clark, RL
机构
[1] Aventis Inc, Dept Drug Safety Evaluat, Bridgewater, NJ 08807 USA
[2] Anentis Inc, Dept Drug Safety Evaluat, Vitry Sur Seine, France
[3] Anentis Inc, Dept Drug Safety Evaluat, Frankfurt, Germany
关键词
developmental toxicity; spiral septal defect; teratology; VLA-4; antagonist; mouse; rat; rabbit;
D O I
10.1002/bdrb.20001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
VLA-4 (Very late antigen 4, integrin alpha(4)beta(1)) plays an important role in cell-cell interactions that are critical for development. Homozygous null knockouts of the alpha(4)subunit of VLA-4 or VCAM-1 (cell surface ligand to VLA-4) in mice result in abnormal placental and cardiac development and embryo lethality. Objectives of the current study were to assess and compare the teratogenic potential of three VLA-4 antagonists. METHODS: IVL745, HMR1031, and IVL984 were each evaluated by the subcutaneous route in standard embryo-fetal developmental toxicity studies in rats and rabbits. IVL984 was also evaluated in mice. Fetuses were examined externally, viscerally, and skeletally. RESULTS: IVL745 did not cause significant maternal or fetal effects at doses up to 100 or 250mg/kg/day in rats or rabbits, respectively HMR1031 treatment resulted in marked maternal toxicity and slight fetal toxicity at the highest tested doses of 200 and 75mg/kg/day in rats and rabbits, respectively. HMR1031 embryo-fetal effects consisted of slightly lower body weight and crown-rump length in rats and minor sternebral defects in rabbits. IVL984 treatment resulted in minimal maternal effects at doses up to 40, 15, and 100mg/kg/day in rats, rabbits, and mice, respectively (excluding abortions in rabbits). However, marked developmental effects were observed at the lowest tested IVL984 doses, 1, 0.2, and 3mg/kg/day in rats, rabbits, and mice, respectively. IVL984 embryo-fetal effects consisted of increased total postimplantation loss due to early resorptions and high incidences of cardiac malformations and skeletal malformations and/or variations. Notably, spiral septal defects were observed in tip to 76% of rat fetuses and up to 58% of rabbit fetuses. CONCLUSIONS: Dramatic differences in teratogenic potential were observed: IVL745 was not teratogenic, HMR1031 caused slight embryo-fetal effects at maternally-toxic doses, and IVL984 was a potent teratogen at doses where direct maternal toxicity was limited to abortions in rabbits. Prominent effects of IVL984 included embryo lethality and cardiac malformations including spiral septal defects in three species. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:55 / 68
页数:14
相关论文
共 20 条
  • [1] The role of integrins in reproduction
    Bowen, JA
    Hunt, JS
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 223 (04): : 331 - 343
  • [2] Critical period for a teratogenic VIA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists
    Crofts, F
    Rohatagi, S
    Pino, M
    DeLise, B
    Zhang, J
    Nguyen, M
    Guittin, P
    Barbellion, S
    Brunel, P
    Hofmann, T
    Schmidt, J
    Wong, M
    Lockey, P
    Lerman, S
    Clark, R
    [J]. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2004, 71 (02) : 69 - 79
  • [3] Adhesive interactions in peri-implantation morphogenesis and placentation
    Damsky, CH
    Schick, SF
    Klimanskaya, I
    Stephens, L
    Zhou, Y
    Fisher, S
    [J]. REPRODUCTIVE TOXICOLOGY, 1997, 11 (2-3) : 367 - 375
  • [4] A note on the staining of the skeleton of cleared - Specimens with alizarin red S
    Dawson, AB
    [J]. STAIN TECHNOLOGY, 1926, 1 (04): : 123 - 124
  • [5] GLADEN B, 1979, J AM STAT ASS, V74
  • [6] TARGETED DISRUPTION OF THE MURINE VCAM1 GENE - ESSENTIAL ROLE OF VCAM-1 IN CHORIOALLANTOIC FUSION AND PLACENTATION
    GURTNER, GC
    DAVIS, V
    LI, HM
    MCCOY, MJ
    SHARPE, A
    CYBULSKY, MI
    [J]. GENES & DEVELOPMENT, 1995, 9 (01) : 1 - 14
  • [7] EXPECTED VALUES OF NORMAL ORDER STATISTICS
    HARTER, HL
    [J]. BIOMETRIKA, 1961, 48 (1-2) : 151 - &
  • [8] HARTUNG J, 1984, MULTIVARIATE STAT
  • [9] Hollander M, 1973, Nonparametric Statistical Methods, P11437
  • [10] MANTEL N, 1959, J NATL CANCER I, V22, P719